Source: International Congress 2016 – Molecular immunology of the lung
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Johan Kolmert (Stockholm, Sweden), Johan Kolmert, Cristina Gomez, Diane Lefaudeux, Bertrand DeMeulder, Anna James, Charles Auffray, Craig Wheelock, Sven-Erik Dahlen. Non-invasive urinary lipid mediator excretion profiles identify sub-phenotypes of asthma in the U-BIOPRED study. Eur Respir J 2016; 48: Suppl. 60, 4954

Member's Comments

No comment yet.

Related content which might interest you: Urinary metabolomics-profiling of the U-BIOPRED asthma study identified biochemical clusters associated with asthma severity Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020 Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016 Lipid biomarkers predictive of gastro-oesophageal reflux in adult asthma Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 Simultaneously increased serum periostin and urinary EDN relates to reduced lung function in adults with asthma from the Swedish GA2LEN study Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 TH2 specific biomarker profile determines steroid responsiveness in severe asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Evaluation of vitamin D in asthma: Its effect on inflammatory markers and clinical profile Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 24-hour blood pressure monitoring and clinical differentiations in patients with bronchial asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Fatty acid blood spectrum in patients with asthma Source: International Congress 2016 – Asthma points to ponder Year: 2016 Urinary metabolomics-based molecular sub-phenotyping of the U-BIOPRED asthma cohort Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017 Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Exhaled fungal microbiome in asthma: Possible association with severity and control Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Assessment of serum magnesium level in patients with bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016 The identification of asthma phenotypes by categorical PCA: Combinatorial analysis of clinical parameters and dysfunctional blood eosinophils Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 LATE-BREAKING ABSTRACT: The study of fibulin-1 as a novel biomarker in bronchial asthma and its association to disease severity Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 Biomarkers of asthma severity in the gene environment interaction in respiratory disease (GEIRD) study Source: International Congress 2014 – Lung function, COPD and inflammation Year: 2014 LATE-BREAKING ABSTRACT: The applicability of urinary leukotriene E4 (uLTE4) measurement as a non-invasive method for diagnosis of aspirin exacerbated respiratory disease (AERD). Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Association between airway bacterial abundance and urinary inflammatory biomarkers in COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020